Clinical Development (US)
Pharmaron provides clinical development services to our global customers in support of international regulatory approval. We have aligned our capabilities and services to meet the drug development industry’s expectation for more thorough evaluation of investigational products in the earlier phases of clinical development. We are unique in offering fully integrated services that includes Carbon-14 radiosynthesis-clinical study-AMS analysis, to accelerate clinical development.
Early Phase Clinical Research
Radiolabelled Carbon-14 Human ADME (Macrotracer/Microtracer)
Vaccine Development/Infectious Disease Studies
Accelerator Mass Spectrometry (AMS)
Interested in partnering with Pharmaron?
Request more information about our drug discovery, preclinical and clinical development services